Trial Profile
Evaluation du système noradrénergique dans l'altération de la perception douloureuse chez le patient Parkinsonien
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Oct 2016
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Pain; Parkinsonian disorders
- Focus Pharmacodynamics
- Acronyms DOULOX
- 01 Oct 2016 Status changed from recruiting to completed.
- 10 Jun 2011 New trial record